4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-21-027903
CEO sold 25,000 shares at an average $107.87 ($2,696,826)
- CEO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2021-07-07 | Option exercise | +25,000 | $1.03 | $25,750 | 1,046,525 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −645 | $100.69 | $64,945 | 1,045,880 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −2,300 | $101.27 | $232,921 | 1,043,580 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −100 | $102.00 | $10,200 | 1,043,480 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −2,864 | $103.52 | $296,481 | 1,040,616 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −1,336 | $104.40 | $139,478 | 1,039,280 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −1,800 | $105.44 | $189,792 | 1,037,480 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −500 | $106.48 | $53,240 | 1,036,980 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −167 | $107.31 | $17,921 | 1,036,813 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −800 | $108.65 | $86,920 | 1,036,013 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −4,800 | $109.58 | $525,984 | 1,031,213 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −3,982 | $110.54 | $440,170 | 1,027,231 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −3,456 | $111.51 | $385,379 | 1,023,775 | D |
| Evans John M. CEO | 2021-07-07 | Sale | −2,250 | $112.62 | $253,395 | 1,021,525 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2021-07-07 | Option exercise · Stock Option (Right to Buy | −25,000 | 371,345 | D | ||
| Open-market sales · 25,000 sh · avg $107.87 · $2,696,826 | |||||||
Loading xslF345X03/doc4.xml…